MedPath

Pimozide

Pimozide Tablets, USP

Approved
Approval ID

70b079e2-a1f7-4a93-8685-d60a4d7c1280

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 25, 2017

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pimozide

PRODUCT DETAILS

NDC Product Code49884-348
Application NumberANDA204521
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateNovember 25, 2017
Generic NamePimozide

INGREDIENTS (5)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
PIMOZIDEActive
Quantity: 2 mg in 1 1
Code: 1HIZ4DL86F
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

Pimozide

PRODUCT DETAILS

NDC Product Code49884-347
Application NumberANDA204521
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateNovember 25, 2017
Generic NamePimozide

INGREDIENTS (5)

PIMOZIDEActive
Quantity: 1 mg in 1 1
Code: 1HIZ4DL86F
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Pimozide - FDA Approval | MedPath